SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001585364-24-000005
Filing Date
2024-02-27
Accepted
2024-02-27 06:40:29
Documents
17
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20240227.htm   iXBRL 8-K 52360
2 EX-99.1 cy23q4ex991pressrelease.htm EX-99.1 975680
7 GRAPHIC perrigoimagenew.jpg GRAPHIC 18151
  Complete submission text file 0001585364-24-000005.txt   1316734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20240227.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20240227_def.xml EX-101.DEF 8180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20240227_lab.xml EX-101.LAB 37274
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20240227_pre.xml EX-101.PRE 20215
19 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20240227_htm.xml XML 7031
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 24681857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)